Pharma Finance and Investment News
Asceneuron secures $100m funding to advance therapeutics in neurodegenerative diseases
Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root cause of neurodegenerative disease, has announced a 100 million USD oversubscribed Series C financing round. Read more
18 Jul 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Rhenopharma Group acquires Swiss contract manufacturer Konapharma AG
Within the new group of companies, Konapharma now complements the services of packaging company Allpack and Rhenochem, a family-owned company with decades of extensive experience and expertise in the global pharmaceutical industry. Read more
1 Jul 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Cycle Pharma Offers $466 Million to Acquire Vanda Pharmaceuticals
Cycle Pharmaceuticals a rapidly growing pharmaceutical company focused on treatments for the underserved rare disease patient community, have confirmed that it made a proposal to the Board of Directors of Vanda Pharmaceuticals, Inc. Read more
10 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Nuclera Awarded £1.14M Innovate UK Funding
Nuclera have announced it has been awarded two highly competitive Innovate UK grants totalling £1.14M. Read more
7 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Alchemab Receive Grant From The Michael J. Fox Foundation
Alchemab Therapeutics has been awarded a grant of $595,000 by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support its Parkinson’s disease program. Read more
7 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Seres to Sell Bacterial Infection Drug to Nestle Health
Seres Therapeutics has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights. Read more
6 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Bionova Scientific Invest $100 Million in New Plasmid DNA Facility
Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, have announced plans to invest $100 million to expand into plasmid DNA (pDNA) production. Read more
4 Jun 2024
Pharma Manufacturing News + Pharma Finance and Investment News
MSD to Acquire EyeBio
MSD and Eyebiotech Limited have announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio. Read more
31 May 2024
Pharma Manufacturing News + Pharma Finance and Investment News
LabGenius Raises £35 Million
LabGenius has closed a £35 million Series B financing round. The investment brings LabGenius’ total funding to date to £58 million. Read more
29 May 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
CARBOGEN AMCIS Passes Two FDA Inspections at its Manufacturing Sites in Switzerland
Both sites in Neuland and Aarau passed the inspection processes with No Actions Indicated (NAIs) identified. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Finish Thompson highlights drum pumps for pharma applications
Finish Thompson Inc. (FTI), a specialist in the corrosive chemical transfer industry, highlights its SFV drum pump, a cost-effective pump designed for container-to-container transfer of acids, corrosives, and chemicals. Read more
26 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
LYVA Labs' Innovate UK Biomedical Catalyst Microbials Accelerator companies secure £857,000 in funding
Nine innovative businesses have received receiving £857k in funding, from the Innovate UK Biomedical Catalyst feasibility grant, after completing LYVA Labs’ Microbials Accelerator programme - the first Innovate UK programme of its kind in this field. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Broken String Biosciences Appoints New Chief Commercial Officer
The newly appointed Steve Becker will help guide the genomics company as it expands its commercial operations. Read more
25 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Sirnaomics announces completion of IND-Enabling studies of safety and efficacy for STP125G with NHP models
Sirnaomics, a leading biopharmaceutical company engaging in the discovery and development of advanced RNAi therapeutics, announced today that it has completed IND-enabling studies for STP125G. Read more
24 Jul 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Enterprise Therapeutics Doses First Person with Cystic Fibrosis with ETD001
As part of the Phase 2a trial, ETD001 aims to clear mucus and increase hydration by targeting the epithelial sodium channel. Read more
24 Jul 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News